<DOC>
	<DOCNO>NCT00709865</DOCNO>
	<brief_summary>The purpose current study ass safety tolerability intravenous tonapofylline .</brief_summary>
	<brief_title>Phase 2b Study Assess Safety Tolerability IV Tonapofylline Subjects With Acute Decompensated Heart Failure ( ADHF ) Renal Insufficiency</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Previous diagnosis heart failure . Must ADHF , require hospitalization , clinical evidence volume overload History allergic reaction xanthinecontaining substance . History seizure History stroke Myocardial infarction Uncorrected hemodynamically significant primary valvular disease know Obstructive restrictive cardiomyopathy . Serious systemic infection Major surgical procedure within 30 day Acute coronary syndrome Cardiogenic shock Baseline body weight &gt; 150 kg Participation investigational study drug device within 30 day prior Screening Nursing mother , pregnant woman , woman plan become pregnant study Presence clinically significant condition might interfere optimal safe participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>renal insufficiency</keyword>
	<keyword>diuretic</keyword>
	<keyword>congestive heart failure</keyword>
	<keyword>acute decompensated heart failure</keyword>
</DOC>